NEW GOLD INC (NGD)

CA6445351068 - Common Stock

1.17  +0.02 (+1.74%)


Fundamental Rating

3

Overall NGD gets a fundamental rating of 3 out of 10. We evaluated NGD against 953 industry peers in the Metals & Mining industry. Both the profitability and financial health of NGD have multiple concerns. NGD has a correct valuation and a medium growth rate.

Note: NGD has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of NGD is 3.00. This is a low score and indicates issues in the health and profitability of NGD.

VS Industry

Valuation

Valuation Rating

5

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the current price to the book value of NGD, it is valued rather cheaply. It is trading at 0.91 times its book value.
Compared to an average industry price book ratio of 1.53, NGD is valued rather cheaply

When comparing the Enterprise Value to EBITDA ratio of NGD to the average industry ratio of 6.51, NGD is valued rather cheaply.
The Forward Price/Earnings Ratio of 12.18 indicates a correct valuation of NGD.
NGD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VS Industry

Price/Book (0.91) VS Industry: 70% outperformed.

200.30
0.03

Enterprise Value/ EBITDA (5.06) VS Industry: 61% outperformed.

568.39
0.24

Growth

Growth Rating

6

The Earnings Per Share is expected to grow by 81.77% on average over the next 5 years. This is a very strong growth
Based on estimates for the next 5 years, NGD will show a quite strong growth in Revenue. The Revenue will grow by 17.64% on average per year.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The Revenue has been growing slightly by 9.23% on average over the past 5 years.
The earnings per share for NGD have decreased strongly by -115.38% in the last year.
Looking at the last year, NGD shows a very negative growth in Revenue. The Revenue has decreased by -16.42% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -115.38% 283.35% 128.07% 105.93% 81.77%
Revenue9.23% -1.4% -16.42% 24.55% 21.25% 17.64% N/A

Health

Health Rating

2

A Current Ratio of 2.28 indicates that NGD has no problem at all paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 2.57.
NGD has a Quick Ratio of 1.48. This is a normal value and indicates that NGD is financially healthy and should not expect problems in meeting its short term obligations.
When comparing the Quick Ratio of NGD to the average industry Current Ratio of 2.11, NGD is less able to pay its short term obligations than its industry peers.

NGD has one of the worst Debt to Equity ratios in its industry. 92% of its industry peers require less debt for financing their operations.
NGD has an Altman-Z score of -0.78. This is a bad value and indicates that NGD is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.25, NGD is in worse financial health than its industry peers.
The Piotroski-F score of NGD is 3.00. This is a low score and indicates issues in the health and profitability of NGD.
VS Industry

Debt/Equity (0.45) VS Industry: 8% outperformed.

9.62
0.00

Quick Ratio (1.48) VS Industry: 39% outperformed.

0.00
178.59

Current Ratio (2.28) VS Industry: 45% outperformed.

0.00
178.59

Altman-Z (-0.78) VS Industry: 29% outperformed.

-2,971.54
2,674.22

Dividend

Dividend Rating

0

NGD does not give a dividend.

NEW GOLD INC

NYSEARCA:NGD (5/30/2023, 12:52:46 PM)

1.17

+0.02 (+1.74%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-26 2023-04-26/amc
Earnings (Next)08-02 2023-08-02/bmo
Inst Owners31.51%
Inst Owner Change-5.35%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap798.26M
Analysts69.33
Price Target1.52 (29.91%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.25%
Min EPS beat(2)-83.35%
Max EPS beat(2)107.86%
EPS beat(4)2
Avg EPS beat(4)-18.41%
Min EPS beat(4)-105.63%
Max EPS beat(4)107.86%
Revenue beat(2)1
Avg Revenue beat(2)1.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)3.44%
Revenue beat(4)2
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-16.21%
Max Revenue beat(4)3.44%
PT rev (1m)7.21%
PT rev (3m)11.36%
EPS NQ rev (1m)60.08%
EPS NQ rev (3m)-54.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.67%
Revenue NQ rev (1m)-4.33%
Revenue NQ rev (3m)4.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.18
P/S 1.26
P/FCF N/A
P/OCF 4.35
P/B 0.91
P/tB 0.91
EV/EBITDA 5.06
EPS(TTM)-0.02
EYN/A
EPS(NY)0.1
Fwd EY8.21%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.27
OCFY22.99%
SpS0.93
BVpS1.29
TBVpS1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 70.6%
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.14%
GM growth 5Y-2.21%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.11
Cap/Depr 138.68%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 1.48
Altman-Z -0.78
F-Score3
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)140.41%
Cap/Depr(5y)122.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-115.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
EPS Next Y283.35%
EPS Next 2Y128.07%
EPS Next 3Y105.93%
EPS Next 5Y81.77%
Revenue growth 1Y-16.42%
Revenue growth 3Y-1.4%
Revenue growth 5Y9.23%
Revenue growth Q2Q15.4%
Revenue Next Year24.55%
Revenue Next 2Y21.25%
Revenue Next 3Y17.64%
Revenue Next 5YN/A
EBIT growth 1Y-108.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1369.52%
EBIT Next 3Y191.02%
EBIT Next 5Y101.17%
FCF growth 1Y-502.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.17%
OCF growth 3Y-10.22%
OCF growth 5Y-11.04%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA